Anne Di Tommaso
Tours, 37200, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Neospora caninum as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapy.
Journal: Molecular therapy. Oncology
Published: July 29, 2024
Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells.
Journal: Frontiers in immunology
Published: January 11, 2024
Nasal administration of recombinant Neospora caninum secreting IL-15/IL-15Rα inhibits metastatic melanoma development in lung.
Journal: Journal for immunotherapy of cancer
Published: April 23, 2023
Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital Toxoplasmosis.
Journal: The Journal of infectious diseases
Published: December 18, 2020
Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer.
Journal: Journal for immunotherapy of cancer
Published: October 02, 2020
Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region Sequences.
Journal: Antibodies (Basel, Switzerland)
Published: March 18, 2020
A method to confer Protein L binding ability to any antibody fragment.
Journal: mAbs
Published: December 20, 2015
Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.
Journal: The Journal of biological chemistry
Published: March 01, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026